US8017121B2
(en)
|
1994-06-30 |
2011-09-13 |
Chugai Seiyaku Kabushika Kaisha |
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
|
EP2077120A3
(de)
*
|
1994-10-07 |
2009-07-15 |
Chugai Seiyaku Kabushiki Kaisha |
Heilmittel für rheumatoide Arthritis mit IL-6-Antagonisten als Aktivsubstanz
|
CZ298790B6
(cs)
*
|
1994-10-21 |
2008-01-30 |
Kishimoto@Tadamitsu |
Farmaceutický prípravek pro prevenci nebo lécení kachexie
|
US6841533B1
(en)
|
1995-12-07 |
2005-01-11 |
Peptor Limited |
Conformationally constrained backbone cyclized interleukin-6 antagonists
|
IL130238A0
(en)
*
|
1999-06-01 |
2000-06-01 |
Peptor Ltd |
Conformationally constrained backbone cyclized interleukin-6 antagonists
|
GB9702944D0
(en)
*
|
1997-02-13 |
1997-04-02 |
Univ Manchester |
Reducing fibrosis
|
DE69839992D1
(de)
|
1997-03-21 |
2008-10-23 |
Chugai Pharmaceutical Co Ltd |
Vorbeugende- oder Heilmittel zur Behandlung von Multipler Sklerose, mit antagonistischen anti-IL6-Rezeptor Antikörpern als Wirkstoff
|
ATE350060T1
(de)
*
|
1998-08-24 |
2007-01-15 |
Chugai Pharmaceutical Co Ltd |
Mittel zur vorbeugung oder behandlung von pankreatitis die anti-il-6 receptor antikörper als aktive komponente enthalten
|
AU7078200A
(en)
|
1999-08-27 |
2001-03-26 |
United States Of America, Represented By The Secretary, Department Of Health And Human Services, The |
Polypeptides, comprising il-6 ligand-binding receptor domains and related nucleic acids, antibodies, compositions, and methods of use
|
ES2298273T3
(es)
|
2000-10-25 |
2008-05-16 |
Chugai Seiyaku Kabushiki Kaisha |
Agentes preventivos o terapeuticos contra la psoriasis que contienen un antagonista de il-6 como su ingrediente activo.
|
AU2002322720B2
(en)
|
2001-07-25 |
2008-11-13 |
Raptor Pharmaceutical Inc. |
Compositions and methods for modulating blood-brain barrier transport
|
CN100374457C
(zh)
*
|
2001-11-14 |
2008-03-12 |
森托科尔公司 |
抗il-6抗体、组合物、方法和用途
|
EP1486566A4
(de)
*
|
2002-03-01 |
2005-10-12 |
Japan Enviro Chemicals Ltd |
Zur bindung an weibliche sexualhormone fähige proteine und verfahren zur herstellung davon
|
AU2002950957A0
(en)
*
|
2002-08-23 |
2002-09-12 |
The Walter And Eliza Hall Institute Of Medical Research |
A method of treatment and prophylaxis
|
DE60329402D1
(de)
*
|
2002-08-23 |
2009-11-05 |
Inst Medical W & E Hall |
Behandlungs- und prophylaxeverfahren
|
EP1673396A1
(de)
*
|
2003-09-22 |
2006-06-28 |
BioVation GmbH & Co.KG. |
Verwendung von antikörpern zur verminderung der biologischen wirksamkeit von il-6
|
US20050100550A1
(en)
*
|
2003-11-10 |
2005-05-12 |
Mohit Trikha |
Anti-angiogenic uses of IL-6 antagonists
|
EP1768662A2
(de)
|
2004-06-24 |
2007-04-04 |
Novartis Vaccines and Diagnostics, Inc. |
Immunstimulatoren kleiner moleküle und assays für deren nachweis
|
US8017395B2
(en)
|
2004-12-17 |
2011-09-13 |
Lifescan, Inc. |
Seeding cells on porous supports
|
EP2392258B1
(de)
|
2005-04-28 |
2014-10-08 |
Proteus Digital Health, Inc. |
Pharma-Informatiksystem
|
JO3058B1
(ar)
|
2005-04-29 |
2017-03-15 |
Applied Molecular Evolution Inc |
الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها
|
JP2009500297A
(ja)
|
2005-06-08 |
2009-01-08 |
セントカー・インコーポレーテツド |
眼の変性についての細胞療法
|
CA2625773C
(en)
|
2005-10-14 |
2015-05-12 |
Fukuoka University |
Inhibition of interleukin-6 (il-6) receptor promotes pancreatic islet transplantation
|
BRPI0617664B8
(pt)
|
2005-10-21 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
uso de um anticorpo que reconhece a il-6 para a produção de uma composição farmacêutica para tratar o enfarte do miocárdio ou suprimir a remodelagem ventricular esquerda depois do enfarte do miocárdio
|
AR057582A1
(es)
|
2005-11-15 |
2007-12-05 |
Nat Hospital Organization |
Agentes para suprimir la induccion de linfocitos t citotoxicos
|
EP1990060B1
(de)
|
2006-01-27 |
2016-09-28 |
Keio University |
Therapeutische mittel zur behandlung von krankheiten im zusammenhang mit choroidaler neovaskularisation
|
WO2007116962A1
(ja)
|
2006-04-07 |
2007-10-18 |
Osaka University |
筋再生促進剤
|
US8741643B2
(en)
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
MX2009002893A
(es)
|
2006-09-18 |
2009-07-10 |
Raptor Pharmaceutical Inc |
Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
|
TWI438208B
(zh)
|
2007-01-23 |
2014-05-21 |
Chugai Pharmaceutical Co Ltd |
抑制慢性排斥反應之藥劑
|
US9080145B2
(en)
|
2007-07-01 |
2015-07-14 |
Lifescan Corporation |
Single pluripotent stem cell culture
|
RU2473685C2
(ru)
|
2007-07-31 |
2013-01-27 |
Лайфскен, Инк. |
Дифференцировка человеческих эмбриональных стволовых клеток
|
RU2473684C2
(ru)
|
2007-11-27 |
2013-01-27 |
Лайфскен, Инк. |
Дифференцировка человеческих эмбриональных стволовых клеток
|
KR102026622B1
(ko)
|
2008-02-21 |
2019-09-30 |
얀센 바이오테크 인코포레이티드 |
세포 부착, 배양 및 탈리를 위한 방법, 표면 개질 플레이트 및 조성물
|
US8623648B2
(en)
|
2008-04-24 |
2014-01-07 |
Janssen Biotech, Inc. |
Treatment of pluripotent cells
|
CA2728243C
(en)
|
2008-06-05 |
2020-03-10 |
National Cancer Center |
Il-6 inhibitor for suppressing neuroinvasion in pancreatic cancer
|
US8188235B2
(en)
|
2008-06-18 |
2012-05-29 |
Pfizer Inc. |
Antibodies to IL-6 and their uses
|
WO2010002846A1
(en)
|
2008-06-30 |
2010-01-07 |
Centocor Ortho Biotech Inc. |
Differentiation of pluripotent stem cells
|
EP2350265B1
(de)
|
2008-10-31 |
2019-04-17 |
Janssen Biotech, Inc. |
Differenzierung menschlicher embryonaler stammzellen in die pankreatisch-endokrine linie
|
CN102272291B
(zh)
|
2008-10-31 |
2018-01-16 |
詹森生物科技公司 |
人胚胎干细胞向胰腺内分泌谱系的分化
|
EP2366022B1
(de)
|
2008-11-20 |
2016-04-27 |
Janssen Biotech, Inc. |
Verfahren und zusammensetzungen zur bindung und kultivierung von zellen auf planaren substraten
|
MX356756B
(es)
|
2008-11-20 |
2018-06-11 |
Centocor Ortho Biotech Inc |
Células madre pluripotentes en microportadores.
|
IL295075A
(en)
|
2009-05-06 |
2022-09-01 |
Laboratory Skin Care Inc |
Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
|
RU2540016C2
(ru)
|
2009-07-20 |
2015-01-27 |
Янссен Байотек, Инк. |
Дифференцировка эмбриональных стволовых клеток человека
|
KR102058901B1
(ko)
|
2009-07-20 |
2019-12-24 |
얀센 바이오테크 인코포레이티드 |
인간 배아 줄기 세포의 분화
|
MX340952B
(es)
|
2009-07-20 |
2016-07-29 |
Janssen Biotech Inc |
Diferenciacion de celulas madre embrionarias humanas.
|
SG10201404340TA
(en)
*
|
2009-07-31 |
2014-10-30 |
Shin Maeda |
Cancer metastasis inhibitor
|
KR101841271B1
(ko)
|
2009-12-23 |
2018-03-22 |
얀센 바이오테크 인코포레이티드 |
인간 배아 줄기 세포의 분화
|
US9150833B2
(en)
|
2009-12-23 |
2015-10-06 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells
|
JP6013196B2
(ja)
|
2010-03-01 |
2016-10-25 |
ヤンセン バイオテツク,インコーポレーテツド |
多能性幹細胞から誘導した細胞を精製するための方法
|
EP2569419B1
(de)
|
2010-05-12 |
2019-03-20 |
Janssen Biotech, Inc. |
Differenzierung menschlicher embryonischer stammzellen
|
EP4115906A1
(de)
|
2010-05-28 |
2023-01-11 |
Chugai Seiyaku Kabushiki Kaisha |
Verstärker der antitumor t-zellenantwort
|
CA2809305C
(en)
|
2010-08-31 |
2019-06-11 |
Janssen Biotech, Inc. |
Differentiation of pluripotent stem cells
|
SG10201506855RA
(en)
|
2010-08-31 |
2015-10-29 |
Janssen Biotech Inc |
Differentiation of human embryonic stem cells
|
BR112013004514A2
(pt)
|
2010-08-31 |
2016-06-07 |
Janssen Biotech Inc |
diferenciação das células-tronco embrionárias humanas
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
WO2012071554A2
(en)
|
2010-11-23 |
2012-05-31 |
Alder Biopharmaceuticals, Inc. |
Anti-il-6 antibodies for the treatment of oral mucositis
|
KR102203056B1
(ko)
|
2011-12-22 |
2021-01-14 |
얀센 바이오테크 인코포레이티드 |
인간 배아 줄기 세포의 단일 인슐린 호르몬 양성 세포로의 분화
|
WO2013134378A1
(en)
|
2012-03-07 |
2013-09-12 |
Janssen Biotech, Inc. |
Defined media for expansion and maintenance of pluripotent stem cells
|
CN108103006A
(zh)
|
2012-06-08 |
2018-06-01 |
詹森生物科技公司 |
人胚胎干细胞向胰腺内分泌细胞的分化
|
RU2658488C2
(ru)
|
2012-12-31 |
2018-06-21 |
Янссен Байотек, Инк. |
Способ получения клеток, экспрессирующих маркеры, характерные для панкреатических эндокринных клеток
|
KR101942769B1
(ko)
|
2012-12-31 |
2019-01-28 |
얀센 바이오테크 인코포레이티드 |
Hb9 조절제를 사용하는 인간 배아 줄기세포의 췌장 내분비 세포로의 분화
|
US10370644B2
(en)
|
2012-12-31 |
2019-08-06 |
Janssen Biotech, Inc. |
Method for making human pluripotent suspension cultures and cells derived therefrom
|
EP4039798A1
(de)
|
2012-12-31 |
2022-08-10 |
Janssen Biotech, Inc. |
Aufhängung und gruppierung von menschlichen pluripotenten zellen
|
DK3143127T3
(da)
|
2014-05-16 |
2021-09-13 |
Janssen Biotech Inc |
Anvendelse af små molekyler til at forstærke mafa-ekspression i endokrine pankreasceller
|
MA45479A
(fr)
|
2016-04-14 |
2019-02-20 |
Janssen Biotech Inc |
Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
|
JP7185884B2
(ja)
|
2017-05-02 |
2022-12-08 |
国立研究開発法人国立精神・神経医療研究センター |
Il-6及び好中球の関連する疾患の治療効果の予測及び判定方法
|
KR20200074160A
(ko)
|
2017-10-20 |
2020-06-24 |
가꼬우호우징 효고 이카다이가쿠 |
항il-6 수용체 항체를 함유하는 수술 후의 유착을 억제하기 위한 의약 조성물
|